Riskpilot← Back to searchSign inGet full accessRhinoklinikken ApS
APSActiveCVR 38219421Strandvejen 104A, 2.Hospital activities · NACE 8610Est. 201627 employeeshttps://www.rhinoklinikken.dk
Revenue 2025
DKK 10,6M
-21% vs 2024
EBITDA margin
-7.6%
-230% vs 2024
Equity ratio
-26.9%
Financial strength
Net profit 2025
DKK -1,4M
-779% vs 2024
| Revenue | DKK 10,6M | -21% |
| EBITDA | DKK -813K | -230% |
| Net profit | DKK -1,4M | -779% |
| Total assets | DKK 4,2M | +9% |
| Equity | DKK -1,1M | -524% |
| Employees | 27 | — |
Legal name
Rhinoklinikken ApS
CVR number
38219421
Legal form
Anpartsselskab
NACE code
8610 · Hospital activities
Founded
16. november 2016
Share capital
DKK 50.000
Employees
27 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at drive privathospital for avanceret næse og bihulekirurgi og hermed ligestillet virksomhed.
Address
Strandvejen 104A, 2.
Phone
+4570212110
Email
info@rhinoklinikken.dk
Website
https://www.rhinoklinikken.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 138 | 5.808 | 7.097 | 9.345 | 9.564 | 10.506 | 8.712 | 13.495 | 10.649 |
| Staff expenses | -514 | -4.940 | -6.310 | -7.604 | -8.717 | -8.888 | -8.450 | -12.869 | -11.462 |
| EBITDA | -376 | 868 | 786 | 1.741 | 847 | 1.618 | 262 | 626 | -813 |
| Depreciation & amort. | -51 | -388 | -409 | -428 | -517 | -493 | -189 | -234 | -401 |
| EBIT | -427 | 480 | 377 | 1.313 | 330 | 1.125 | 73 | 393 | -1.214 |
| Net financials | -37 | -65 | -79 | -60 | -39 | -37 | -45 | -88 | -185 |
| Profit before tax | -464 | 415 | 298 | 1.253 | 291 | 1.087 | 28 | 305 | -1.399 |
| Tax | 49 | -50 | 83 | 302 | 77 | 266 | 17 | 98 | 6 |
| Net profit | -513 | 464 | 215 | 951 | 214 | 822 | 11 | 207 | -1.405 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.533 | 2.566 | 2.854 | 3.477 | 2.187 | 2.122 | 2.381 | 3.868 | 4.231 |
| Equity | -463 | 2 | 217 | 1.002 | 316 | 522 | 61 | 268 | -1.137 |
| Long-term debt | 0 | 708 | 548 | 387 | 197 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.947 | 1.856 | 2.036 | 2.070 | 1.674 | 1.600 | 2.319 | 3.600 | 5.368 |
| Total debt | 1.947 | 2.564 | 2.584 | 2.457 | 1.871 | 1.600 | 2.319 | 3.600 | 5.368 |
EBITDA margin
-7.6%
This company
15.8%
Market median
-148% vs market
20172025
Equity ratio
-26.9%
This company
38.2%
Market median
-170% vs market
20172025
Return on equity
-140521300.0%
This company
18.4%
Market median
-763702817% vs market
20172025
Net profit margin
-13.2%
This company
8.1%
Market median
-263% vs market
20172025
Asset turnover
2.52×
This company
1.12×
Market median
+125% vs market
20172025
Debt / equity
4.72×
This company
0.62×
Market median
-661% vs market
20172025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2016-11-16 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HB Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
NR Management | Management | 2016 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Henrik Bredahl Holding ApS | Company | 50.0% | 50.0% | 2016 |
Smiasg Holding ApS | Company | 50.0% | 50.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Smiasg Holding ApS
Rhinoklinikken ApS Board members of Rhinoklinikken ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Bredahl | Chief Executive Officer | 0 companies |
| Niclas Rubek | Management | 0 companies |